JP2024546841A5 - - Google Patents
Info
- Publication number
- JP2024546841A5 JP2024546841A5 JP2024535360A JP2024535360A JP2024546841A5 JP 2024546841 A5 JP2024546841 A5 JP 2024546841A5 JP 2024535360 A JP2024535360 A JP 2024535360A JP 2024535360 A JP2024535360 A JP 2024535360A JP 2024546841 A5 JP2024546841 A5 JP 2024546841A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- nucleic acid
- cas9
- target nucleic
- rna guide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291252P | 2021-12-17 | 2021-12-17 | |
| US63/291,252 | 2021-12-17 | ||
| PCT/US2022/081728 WO2023114953A2 (en) | 2021-12-17 | 2022-12-16 | Novel crispr enzymes, methods, systems and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546841A JP2024546841A (ja) | 2024-12-26 |
| JP2024546841A5 true JP2024546841A5 (https=) | 2025-12-11 |
Family
ID=85172990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535360A Pending JP2024546841A (ja) | 2021-12-17 | 2022-12-16 | 新規ｃｒｉｓｐｒ酵素、方法、システム、及びそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240327813A1 (https=) |
| EP (1) | EP4448772A2 (https=) |
| JP (1) | JP2024546841A (https=) |
| KR (1) | KR20240116827A (https=) |
| CN (1) | CN119095968A (https=) |
| AU (1) | AU2022413670A1 (https=) |
| CA (1) | CA3240917A1 (https=) |
| WO (1) | WO2023114953A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121079412A (zh) | 2023-04-28 | 2025-12-05 | 比姆医疗股份有限公司 | 经修饰的指导rna |
| CN121294400A (zh) * | 2024-07-08 | 2026-01-09 | 华熙生物科技股份有限公司 | 一种Cas蛋白及其基因编辑系统和应用 |
| CN119876089A (zh) * | 2025-01-10 | 2025-04-25 | 上海市浦东医院（复旦大学附属浦东医院） | 基于SeqCas9蛋白的CRISPR/Cas9基因编辑系统及其相关应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| US5587308A (en) | 1992-06-02 | 1996-12-24 | The United States Of America As Represented By The Department Of Health & Human Services | Modified adeno-associated virus vector capable of expression from a novel promoter |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| AU2005274948B2 (en) | 2004-07-16 | 2011-09-22 | Genvec, Inc. | Vaccines against aids comprising CMV/R-nucleic acid constructs |
| US8404658B2 (en) | 2007-12-31 | 2013-03-26 | Nanocor Therapeutics, Inc. | RNA interference for the treatment of heart failure |
| US9405700B2 (en) | 2010-11-04 | 2016-08-02 | Sonics, Inc. | Methods and apparatus for virtualization in an integrated circuit |
| IL310721B2 (en) | 2015-10-23 | 2025-11-01 | Harvard College | Nucleobase editors and uses thereof |
| CN110214183A (zh) | 2016-08-03 | 2019-09-06 | 哈佛大学的校长及成员们 | 腺苷核碱基编辑器及其用途 |
| SG11201906297QA (en) * | 2017-03-24 | 2019-10-30 | Curevac Ag | Nucleic acids encoding crispr-associated proteins and uses thereof |
-
2022
- 2022-12-16 CA CA3240917A patent/CA3240917A1/en active Pending
- 2022-12-16 AU AU2022413670A patent/AU2022413670A1/en active Pending
- 2022-12-16 EP EP22854331.0A patent/EP4448772A2/en active Pending
- 2022-12-16 WO PCT/US2022/081728 patent/WO2023114953A2/en not_active Ceased
- 2022-12-16 KR KR1020247023120A patent/KR20240116827A/ko active Pending
- 2022-12-16 JP JP2024535360A patent/JP2024546841A/ja active Pending
- 2022-12-16 CN CN202280091591.0A patent/CN119095968A/zh active Pending
-
2024
- 2024-06-07 US US18/736,840 patent/US20240327813A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024511621A5 (https=) | ||
| US20230047669A1 (en) | Compositions and methods of improving specificity in genomic engineering using rna-guided endonucleases | |
| JP2024546841A5 (https=) | ||
| AU2020267249B2 (en) | Genome editing using campylobacter jejuni crispr/cas system-derived rgen | |
| JP2022546608A5 (https=) | ||
| CA3129158A1 (en) | Adenosine deaminase base editors and methods of using same to modify a nucleobase in a target sequence | |
| US20240141341A1 (en) | Systems and methods for genome-wide annotation of gene regulatory elements linked to cell fitness | |
| JP2022545950A5 (https=) | ||
| Locatelli et al. | Autologous gene therapy for hemoglobinopathies: From bench to patient’s bedside | |
| IL261714B1 (en) | Crispr/cas-related methods and compositions for treating beta hemoglobinopathies | |
| US12129478B1 (en) | Engineered adenosine deaminases and base editors thereof | |
| WO2017215648A1 (zh) | 基因敲除方法 | |
| US20240058425A1 (en) | Systems and methods for genome-wide annotation of gene regulatory elements linked to cell fitness | |
| Mosterd et al. | Characterization of a type II-A CRISPR-Cas system in Streptococcus mutans | |
| JP2025517515A (ja) | 新規核酸編集タンパク質 | |
| JPS61501747A (ja) | 核酸配列の検出方法 | |
| CN118871578A (zh) | 用于碱基编辑的脱氨酶及其变体 | |
| BR112021010186A2 (pt) | Agente de corte de dna, métodos associados e seus usos | |
| JP7835414B2 (ja) | プライム編集システムを用いたゲノム編集のプロセスで起こり得るオフターゲットを予測するための方法 | |
| CN119162157B (zh) | 用于碱基编辑的脱氨酶及其变体 | |
| WO2025190256A1 (en) | Type ii cas protein and uses thereof | |
| JP7621281B2 (ja) | 細菌、肺パスツレラ菌（Ｐａｓｔｅｕｒｅｌｌａ ｐｎｅｕｍｏｔｒｏｐｉｃａ）由来のＣａｓ９タンパク質に基づくＤＮＡカット剤 | |
| Mehmood | Recombinant DNA Technology | |
| Yu et al. | Structure-guided discovery and engineering of miniature CRISPR-Cas12m for epigenome editing | |
| Shapiro | Drugs Affecting Trypanosome Topoisomeroses |